Insidra
INSIDRA

Trading Intelligence

DL
Denis Lucquin
Director

Denis Lucquin insider trades: BioAmber (BIOA) SEC Form 4 filings

Director, BioAmber 3 Form 4 filings
3
Form 4 filings
last May 29, 2014
2
Grants and awards
filings
1
Other transactions
filings
2
Companies

Companies

Where Denis reports to the SEC

BIOA
BIOABioAmber
Director · last filing May 29, 2014
No market trades
BIOA.U
BIOA.UBioAmber
Director · last filing May 16, 2013
No market trades

Other BIOA insiders

Open-market trades in the last 12 months

Shane Barton
Principal Accounting Officer
1 sale
Jun 30, 2026
Paul D Rubin
Chief Medical Officer
6 sales
Apr 1, 2026
Dov A Md Goldstein
Chief Financial Officer
1 sale
Jan 13, 2026
Kristen Fortney
Chief Executive Officer
1 sale
Jan 13, 2026

About Denis Lucquin's insider trades

Denis Lucquin is a director at BioAmber (BIOA). Denis has not reported an open-market purchase or sale.

Their filings also include grants and awards (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BIOA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.